← FDA Drug Approvals (Drugs@FDA)

LAMOTRIGINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMRING PHARMS · Approved 2022-02-03

Drug application

FDA Application #

ANDA214124

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMOTRIGINE

Generic name

LAMOTRIGINE

Active ingredients

LAMOTRIGINE

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Prescription

Sponsor

AMRING PHARMS

Manufacturer

Nordic Pharma, Inc.

First approval

2022-02-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown